All Stories

  1. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients

    Article • Journal of Thrombosis and Haemostasis, June 2018, Wiley

    Dr Gary W Moore, Petr Smejkal

  2. The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura

    Article • British Journal of Haematology, April 2018, Wiley

    Dr Gary W Moore

  3. Lupus anticoagulant mixing tests for multiple reagents are more sensitive if interpreted with a mixing test-specific cut-off than index of circulating anticoagulant

    Article • Research and Practice in Thrombosis and Haemostasis, December 2017, Wiley

    Osamu Kumano, Dr Gary W Moore

  4. Reference interval mean clotting times should not be used to calculate lupus anticoagulant mixing test ratios unless they match the normal pooled plasma clotting time

    Article • Thrombosis Research, November 2017, Elsevier

    Dr Gary W Moore

  5. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study

    Article • BMC Nephrology, October 2017, Springer Science + Business Media

    Dr Gary W Moore, Dr Marlies Ostermann

  6. Application of different lupus anticoagulant diagnostic algorithms to the same assay data leads to interpretive discrepancies in some samples

    Article • Research and Practice in Thrombosis and Haemostasis, June 2017, Wiley

    Dr Gary W Moore

  7. Newly developed dilute Russell’s viper venom reagents for lupus anticoagulant detection with improved specificity

    Article • Lupus, May 2017, SAGE Publications

    Dr Gary W Moore

  8. Current Controversies in Lupus Anticoagulant Detection

    Article • Antibodies, December 2016, MDPI AG

    Dr Gary W Moore

  9. Platelet-rich plasma for tissue regeneration can be stored at room temperature for at least five days

    Article • British Journal of Biomedical Science, October 2016, Taylor & Francis

    Dr Gary W Moore

  10. Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients

    Article • Blood Coagulation & Fibrinolysis, June 2016, Wolters Kluwer Health

    Dr Gary W Moore

  11. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant

    Article • Thrombosis Research, March 2016, Elsevier

    Dr Gary W Moore

  12. Maximising the diagnostic potential of APTT-based screening assays for activated protein C resistance

    Article • International Journal of Laboratory Hematology, August 2015, Wiley

    Dr Gary W Moore

  13. A diagnostic dilemma: variant Bernard-Soulier syndrome, a difficult clinical and genetic diagnosis

    Article • Haemophilia, July 2015, Wiley

    Dr Gary W Moore

  14. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A

    Article • Thrombosis and Haemostasis, June 2015, Schattauer GmbH

    Dr Gary W Moore

  15. Endothelial and platelet microparticles in patients with antiphospholipid antibodies

    Article • Thrombosis Research, February 2015, Elsevier

    Dr Gary W Moore

  16. Development of a novel, rapid assay for detection of heparin-binding defect antithrombin deficiencies: the heparin-antithrombin binding (HAB) ratio

    Article • Thrombosis Research, January 2015, Elsevier

    Dr Gary W Moore

  17. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection

    Article • International Journal of Laboratory Hematology, April 2014, Wiley

    Dr Gary W Moore

  18. Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants

    Article • Seminars in Thrombosis and Hemostasis, February 2014, Thieme Publishing Group

    Dr Gary W Moore

  19. Complete prekallikrein deficiency masquerading as a lupus anticoagulant

    Article • Thrombosis Research, February 2014, Elsevier

    Dr Gary W Moore

  20. High sensitivity and specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies

    Article • International Journal of Laboratory Hematology, August 2013, Wiley

    Dr Gary W Moore

  21. How I treat heterozygous hereditary antithrombin deficiency in pregnancy

    Article • Thrombosis and Haemostasis, August 2013, Schattauer GmbH

    Dr Gary W Moore

  22. Lupus anticoagulant detection: out of control?

    Article • International Journal of Laboratory Hematology, September 2012, Wiley

    Dr Gary W Moore

  23. Levels of fibrinogen and thromboelastometry fibrin polymerisation following treatment with desmopressin (DDAVP)

    Article • Thrombosis Research, April 2012, Elsevier

    Dr Gary W Moore

  24. Guidelines on the investigation and management of antiphospholipid syndrome

    Article • British Journal of Haematology, February 2012, Wiley

    Dr Gary W Moore

  25. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome

    Article • Thrombosis and Haemostasis, January 2012, Schattauer GmbH

    Dr Gary W Moore

  26. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders

    Article • Transfusion, June 2010, Wiley

    Dr Gary W Moore

  27. Haemostasis screening

    Article • British Journal of Hospital Medicine, August 2009, Mark Allen Group

    Dr Gary W Moore

  28. The Activated Seven Lupus Anticoagulant Assay Detects Clinically Significant Antibodies

    Article • Clinical and Applied Thrombosis/Hemostasis, June 2008, SAGE Publications

    Dr Gary W Moore

  29. Acquired prothrombin deficiency in a patient with follicular lymphoma

    Article • Haemophilia, May 2008, Wiley

    Dr Gary W Moore

  30. Further evidence of false negative screening for lupus anticoagulants

    Article • Thrombosis Research, January 2008, Elsevier

    Dr Gary W Moore

  31. Clinically significant differences between point-of-care analysers and a standard analyser for monitoring the International Normalized Ratio in oral anticoagulant therapy: a multi-instrument evaluation in a hospital outpatient setting

    Article • Blood Coagulation & Fibrinolysis, April 2007, Wolters Kluwer Health

    Dr Gary W Moore

  32. Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients

    Article • Thrombosis Journal, January 2007, Springer Science + Business Media

    Dr Gary W Moore

  33. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied

    Article • Thrombosis Research, January 2006, Elsevier

    Dr Gary W Moore

  34. A new-generation dilute Russell’s viper venom time assay system for lupus anticoagulants: evaluation of detection utilising frozen reagents and controls

    Article • British Journal of Biomedical Science, January 2005, Taylor & Francis

    Dr Gary W Moore

  35. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy

    Article • British Journal of Biomedical Science, January 2005, Taylor & Francis

    Dr Gary W Moore

  36. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma

    Article • International Journal of Laboratory Hematology, December 2004, Wiley

    Dr Gary W Moore

  37. Heterogeneity of Russell's viper venom affects the sensitivity of the dilute Russell's viper venom time to lupus anticoagulants

    Article • Blood Coagulation & Fibrinolysis, April 2004, Wolters Kluwer Health

    Dr Gary W Moore

  38. The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants

    Article • Blood Coagulation & Fibrinolysis, April 2003, Wolters Kluwer Health

    Dr Gary W Moore

  39. The Activated Seven Lupus Anticoagulant (ASLA) assay: a new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway-based assays

    Article • Blood Coagulation & Fibrinolysis, April 2002, Wolters Kluwer Health

    Dr Gary W Moore

  40. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time

    Article • Blood Coagulation & Fibrinolysis, December 2000, Wolters Kluwer Health

    Dr Gary W Moore

  41. Rapid Genetic Diagnosis in Neonatal Pulmonary Artery Thrombosis Caused by Homozygous Antithrombin Budapest 3

    Article • Clinical and Applied Thrombosis/Hemostasis, July 2000, SAGE Publications

    Dr Gary W Moore

  42. Heterozygous factor XI deficiency associated with three novel mutations

    Article • British Journal of Haematology, December 1999, Wiley

    Dr Gary W Moore